Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLAMES: Inflammation and Stress Sensitivity
NCT06620679Recruiting
- Sponsor
- UZ Leuven
- Start
- May 2024
- Primary completion
- Dec 2026
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, triple-blind trial of lipopolysaccharide endotoxin (2 arms), sponsored by UZ Leuven. Primary endpoints: Blood-oxygenation-level-dependent functional magnetic resonance imaging response to acute stress task and Binding potential of [18F]-DPA-714 radiotracer. Started May 2024; status: recruiting.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NCT06620679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06620679.